Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
PK/PD Study of Intranasal Insulin in Type I Diabetes (NCT01201278)Hompesch, Marcus, M.D.
A Study of PMPA in HIV-Infected Patients (NCT00002180)Gilead Sciences
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fed Conditions (NCT01928069)Torrent Pharmaceuticals Limited
Safety and Tolerability of Z-100 in Patients With Early HIV Infection (NCT00016692)Zeria Pharmaceutical
Piracetam for Treatment of Cocaine Addiction, Phase II - 4 (NCT00000199)University of Pennsylvania
An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive (NCT00000721)National Institute of Allergy and Infectious Diseases (NIAID)
Evaluating Therapeutic Massage for Chronic Neck Pain (NCT00065416)National Center for Complementary and Integrative Health (NCCIH)
Ph1 Lobeline Interaction Study - 1 (NCT00439504)National Institute on Drug Abuse (NIDA)
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets Under Fasting Conditions (NCT01800227)Torrent Pharmaceuticals Limited
Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA (NCT00006431)National Center for Research Resources (NCRR)
Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C (NCT00633230)University of Virginia
Adding New Drugs for HIV Infected Patients Failing Current Therapy (NCT00031044)National Institute of Allergy and Infectious Diseases (NIAID)
A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers (NCT00645554)Xian-Janssen Pharmaceutical Ltd.
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma (NCT00000689)National Institute of Allergy and Infectious Diseases (NIAID)
Urokinase Versus Primary Video-Assisted Thorascopic Surgery for Empyema (NCT00144950)Institute of Child Health
Influence of Administration Route of Testosterone on Male Fertility (NCT00705796)Acerus Pharmaceuticals Corporation
An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV (NCT00027365)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of AMG 114 Administered by Subcutaneous Injection for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies Receiving Multicycle Chemotherapy (NCT00119600)Amgen
A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers (NCT00000832)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fed Condition (NCT01218698)Torrent Pharmaceuticals Limited
Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy (NCT00002209)Centaur Pharmaceuticals
Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults (NCT00614640)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00001113)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema (NCT00308542)Sanwa Kagaku Kenkyusho Co., Ltd.
The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients (NCT00001074)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of Methotrexate for HIV Infection (NCT00000834)National Institute of Allergy and Infectious Diseases (NIAID)
A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC. (NCT00000704)National Institute of Allergy and Infectious Diseases (NIAID)
Paper Applicator Acceptability Study (NCT02179138)CONRAD
The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure (NCT00175110)Tufts University
A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease. (NCT00002111)Stanford University
Radioimmunotherapy (RIT) in MULTIPLE MYELOMA Using the Antibody B-B4 Radiolabelled With IODE 131 (NCT01296204)Centre René Gauducheau
A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes (NCT00001012)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma (NCT00000763)National Institute of Allergy and Infectious Diseases (NIAID)
Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant (NCT00001019)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions (NCT01418612)Torrent Pharmaceuticals Limited
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection (NCT00006630)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC) (NCT00001009)National Institute of Allergy and Infectious Diseases (NIAID)
Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT00006235)Gynecologic Oncology Group
Pharmacokinetic Characterization of Intramuscular Olanzapine Depot (NCT00094640)Eli Lilly and Company
A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis (NCT00210340)International Extranodal Lymphoma Study Group (IELSG)
Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men (NCT00063804)National Institute of Allergy and Infectious Diseases (NIAID)
Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer (NCT02575508)Roswell Park Cancer Institute
An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) (NCT00000649)Boehringer Ingelheim
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia (NCT00002148)University of Rochester
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors (NCT00225550)Adherex Technologies, Inc.
HIV Educational Programs for Villagers of Funan County or Yingzhou District, Anhui Province, China (NCT00068991)National Institute of Allergy and Infectious Diseases (NIAID)
A Skin Stretching Wound Closure System (NCT01069614)Hillel Yaffe Medical Center
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients (NCT00002248)Univax Biologics Inc
Evaluating the Safety of and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults in Uganda (NCT01549470)National Institute of Allergy and Infectious Diseases (NIAID)
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults (NCT01964937)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant Couples (NCT00000928)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. (NCT00002138)Daiichi Pharmaceuticals
Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth (NCT00491413)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Safety Study of an Oral Vitamin D Analog in Postmenopausal Women (NCT01969656)Deltanoid Pharmaceuticals
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Clopidogrel Tablets Under Fed Condition (NCT01630915)Torrent Pharmaceuticals Limited
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients (NCT00002396)Gilead Sciences
A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women (NCT00000839)National Institute of Allergy and Infectious Diseases (NIAID)
A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only) (NCT00000958)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Felodipine Extended-Release Tablets Under Fasting Condition (NCT01630655)Torrent Pharmaceuticals Limited
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fasted Conditions (NCT01990378)Torrent Pharmaceuticals Limited
A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant Women (NCT00000862)National Institute of Allergy and Infectious Diseases (NIAID)
Anesthetic Efficacy of Intrauterine Lidocaine for Removal of a "Lost" Intrauterine Device (NCT00308841)Suleyman Demirel University
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease (NCT00000805)National Institute of Allergy and Infectious Diseases (NIAID)
Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck (NCT01491139)University College, London
Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump (NCT01430000)Medgenics Medical Israel Ltd.
Investigation of Cannabis for Chronic Pain and Palliative Care (NCT02683018)New York State Psychiatric Institute
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Topiramate Tablets Under Fed Conditions (NCT00939705)Torrent Pharmaceuticals Limited
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects (NCT00002353)United Biomedical
Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer (NCT00097383)Eli Lilly and Company
Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia (NCT00234481)Exelixis
Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers (NCT00039975)National Institute of Allergy and Infectious Diseases (NIAID)
Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza (NCT01063933)National Institute of Allergy and Infectious Diseases (NIAID)
Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT01017822)Radiation Therapy Oncology Group
hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure (NCT00008801)National Center for Research Resources (NCRR)
A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions (NCT00990301)Paddock Laboratories, Inc.
Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery (NCT00540605)National Institute of Allergy and Infectious Diseases (NIAID)
VEGF Gene Transfer for Critical Limb Ischemia (NCT00304837)Losordo, Douglas, M.D.
Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fasting Conditions. (NCT01089192)Torrent Pharmaceuticals Limited
A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults (NCT00002204)Chiron Corporation
A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants (NCT00000829)National Institute of Allergy and Infectious Diseases (NIAID)
Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition (NCT00939835)Torrent Pharmaceuticals Limited
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors (NCT00004580)Abbott
A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS (NCT00002116)Gilead Sciences
Single Dose Pharmacokinetics of Oral Dextran Sulfate (UA001) and Intravenous Dextran Sulfate in Healthy Volunteers (NCT00000690)National Institute of Allergy and Infectious Diseases (NIAID)
TG4040 in Patients With Chronic HCV (NCT00449124)National Institute of Allergy and Infectious Diseases (NIAID)
Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia (NCT00030355)National Cancer Institute (NCI)
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fasting Conditions (NCT01418417)Torrent Pharmaceuticals Limited
Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3. (NCT00000818)National Institute of Allergy and Infectious Diseases (NIAID)
Mind-Body Exercise for COPD: A Pilot Study (NCT01007903)Beth Israel Deaconess Medical Center
A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection (NCT00000760)National Institute of Allergy and Infectious Diseases (NIAID)
Study of Effects of Low Level Laser Therapy in the Physical Training and the Muscle Responses in Humans. (NCT01113021)Universidade Federal de Sao Carlos
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults (NCT00001052)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir (NCT00000668)National Institute of Allergy and Infectious Diseases (NIAID)
Prevention of Steroid-Induced Osteoporosis in Children (NCT00022841)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas (NCT01600807)Dana-Farber Cancer Institute
D-Serine Monotherapy for Schizophrenia (NCT00215917)Herzog Hospital
Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India (NCT00081640)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine (NCT00722774)National Institute of Allergy and Infectious Diseases (NIAID)
Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects (NCT02614352)Ahn-Gook Pharmaceuticals Co.,Ltd
Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection. (NCT00002175)The Honolulu Medical Group
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.